Cargando…
A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis
The need for new therapeutics for Ankylosing Spondylitis (AS) is highlighted by the general lack of efficacy for most agents currently available for this disease. Many recent studies have detailed molecular pathways in AS, and several molecule-targeting agents are undergoing evaluation. We aimed to...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268298/ https://www.ncbi.nlm.nih.gov/pubmed/23090024 http://dx.doi.org/10.3390/molecules171012460 |
_version_ | 1783376254614896640 |
---|---|
author | Chen, Kai Zhao, Yingchuan Chen, Yu Wang, Chuanfeng Chen, Ziqiang Bai, Yushu Zhu, Xiaodong Li, Ming |
author_facet | Chen, Kai Zhao, Yingchuan Chen, Yu Wang, Chuanfeng Chen, Ziqiang Bai, Yushu Zhu, Xiaodong Li, Ming |
author_sort | Chen, Kai |
collection | PubMed |
description | The need for new therapeutics for Ankylosing Spondylitis (AS) is highlighted by the general lack of efficacy for most agents currently available for this disease. Many recent studies have detailed molecular pathways in AS, and several molecule-targeting agents are undergoing evaluation. We aimed to explore the mechanism of AS and identify biologically active small molecules capable of targeting the sub-pathways which were disregulated in the development of AS. By using the GSE25101 microarray data accessible from the Gene Expression Omnibus database, we first identified the differentially expressed genes (DEGs) between AS samples and healthy controls, followed by the sub-pathway enrichment analysis of the DEGs. In addition, we propose the use of an approach based on targeting sub-pathways to identify potential agents for AS. A total of 3,280 genes were identified as being significantly different between patients and controls with p-values < 0.1. Our study showed that neurotrophic signaling pathway and some immune-associated pathways may be involved in the development of AS. Besides, our bioinformatics analysis revealed a total of 15 small molecules which may play a role in perturbing the development of AS. Our study proposes the use of an approach based on targeting sub-pathways to identify potential agents for AS. Candidate agents identified by our approach may provide the groundwork for a combination therapy approach for AS. |
format | Online Article Text |
id | pubmed-6268298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62682982018-12-12 A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis Chen, Kai Zhao, Yingchuan Chen, Yu Wang, Chuanfeng Chen, Ziqiang Bai, Yushu Zhu, Xiaodong Li, Ming Molecules Article The need for new therapeutics for Ankylosing Spondylitis (AS) is highlighted by the general lack of efficacy for most agents currently available for this disease. Many recent studies have detailed molecular pathways in AS, and several molecule-targeting agents are undergoing evaluation. We aimed to explore the mechanism of AS and identify biologically active small molecules capable of targeting the sub-pathways which were disregulated in the development of AS. By using the GSE25101 microarray data accessible from the Gene Expression Omnibus database, we first identified the differentially expressed genes (DEGs) between AS samples and healthy controls, followed by the sub-pathway enrichment analysis of the DEGs. In addition, we propose the use of an approach based on targeting sub-pathways to identify potential agents for AS. A total of 3,280 genes were identified as being significantly different between patients and controls with p-values < 0.1. Our study showed that neurotrophic signaling pathway and some immune-associated pathways may be involved in the development of AS. Besides, our bioinformatics analysis revealed a total of 15 small molecules which may play a role in perturbing the development of AS. Our study proposes the use of an approach based on targeting sub-pathways to identify potential agents for AS. Candidate agents identified by our approach may provide the groundwork for a combination therapy approach for AS. MDPI 2012-10-22 /pmc/articles/PMC6268298/ /pubmed/23090024 http://dx.doi.org/10.3390/molecules171012460 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Chen, Kai Zhao, Yingchuan Chen, Yu Wang, Chuanfeng Chen, Ziqiang Bai, Yushu Zhu, Xiaodong Li, Ming A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis |
title | A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis |
title_full | A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis |
title_fullStr | A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis |
title_full_unstemmed | A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis |
title_short | A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis |
title_sort | sub-pathway based method to identify candidate agents for ankylosing spondylitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268298/ https://www.ncbi.nlm.nih.gov/pubmed/23090024 http://dx.doi.org/10.3390/molecules171012460 |
work_keys_str_mv | AT chenkai asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT zhaoyingchuan asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT chenyu asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT wangchuanfeng asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT chenziqiang asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT baiyushu asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT zhuxiaodong asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT liming asubpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT chenkai subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT zhaoyingchuan subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT chenyu subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT wangchuanfeng subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT chenziqiang subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT baiyushu subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT zhuxiaodong subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis AT liming subpathwaybasedmethodtoidentifycandidateagentsforankylosingspondylitis |